Download Sample
Add to CartGlobal Pet Diabetes Care Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Drug Type;
Insulin Therapy and Oral MedicationBy Animal Type;
Cats, Dogs, and HorsesBy Device Type;
Insulin Delivery Devices, Insulin Delivery Pen, Insulin Syringes, and Glucose Monitoring DevicesBy End User;
Veterinary Clinics, Home Care Settings, Veterinary HospitalsBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Pet Diabetes Care Market Overview
Pet Diabetes Care Market (USD Million)
Pet Diabetes Care Market was valued at USD 2,773.14 million in the year 2024. The size of this market is expected to increase to USD 4,424.01 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.9%.
Global Pet Diabetes Care Market Growth, Share, Size, Trends and Forecast
*Market size in USD million
CAGR 6.9 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.9 % |
| Market Size (2024) | USD 2,773.14 Million |
| Market Size (2031) | USD 4,424.01 Million |
| Market Concentration | Medium |
| Report Pages | 400 |
Major Players
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Global Pet Diabetes Care Market
Fragmented - Highly competitive market without dominant players
The Pet Diabetes Care Market is experiencing substantial growth, driven by the rising incidence of diabetes in companion animals. Increased awareness among pet owners regarding early disease detection and management has significantly influenced market trends. Diabetes prevalence in pets has climbed by over 30%, largely attributed to poor diet and low activity levels. Improved diagnostic capabilities are enhancing disease identification and treatment rates.
Technology-Driven Diabetes Management Solutions
The market is seeing a sharp rise in the demand for insulin treatments and blood glucose monitors tailored for pets. With around 40% of diabetic pet owners now relying on digital monitoring tools, the shift toward advanced care technologies is evident. These innovations support better disease management and offer convenience to pet owners managing chronic conditions at home.
Spending Trends in Veterinary Care
A strong increase of more than 25% in pet healthcare spending has been recorded, with diabetes care accounting for a growing share of this expenditure. The ongoing trend of treating pets as family members has prompted owners to invest more in specialized and preventive care solutions, boosting the adoption of high-quality diabetes treatment options for animals.
Innovative Product Offerings Enhancing Growth
Rapid innovation in diabetes management products has further accelerated market expansion. Over 35% of new launches in pet health are focused on diabetes control, including glucose sensors and user-friendly insulin options. Distribution strategies through online channels and veterinary networks have increased product accessibility and customer reach, especially in urban markets.
Supportive Regulations and Technological Integration
Regulatory agencies are supporting improved pet health standards, while advances in veterinary diagnostics and personalized medicine are transforming diabetes care. Technologies like AI-powered vet devices are helping tailor treatment protocols, contributing to a market expansion rate exceeding 28%. These clinical and tech-driven developments continue to reshape the landscape of pet diabetes management.
Pet Diabetes Care Market Recent Developments
-
In July 2024, Dechra Limited acquired Akston Biosciences’ long‑acting veterinary insulin programs, securing global rights and IP for innovative canine and feline diabetes treatments and advancing its position in pet diabetes care.
-
In 2022, Zoetis Inc. launched pet-specific glucose monitoring devices that enable real-time tracking and better management of diabetes in cats and dogs.
Pet Diabetes Care Market Segment Analysis
In this report, the Pet Diabetes Care Market has been segmented by Drug Type, Animal Type, Device Type, End User, and Geography.
Pet Diabetes Care Market, Segmentation by Drug Type
The Pet Diabetes Care Market has been segmented by Drug Type into Insulin Therapy and Oral Medication.
Insulin Therapy
Insulin therapy leads the pet diabetes care market, comprising about 75% of the global segment. Its widespread use is primarily due to its proven effectiveness in managing Type 1 diabetes, particularly in dogs. With increasing adoption of veterinary-specific insulin formulations, pet owners are seeing better blood sugar control outcomes. Growing awareness campaigns and strong endorsements from veterinarians are also driving demand.
Oral Medication
Oral medication accounts for nearly 25% of the pet diabetes treatment market. This method is particularly favored for cats in the early stages of Type 2 diabetes due to its convenient administration. Though less dominant than insulin, oral options are gaining momentum thanks to their cost-effectiveness and ease of use. Ongoing research into novel pet-friendly antidiabetic drugs is expected to further stimulate growth in this segment.
Pet Diabetes Care Market, Segmentation by Animal Type
The Pet Diabetes Care Market has been segmented by Animal Type into Cats, Dogs, and Horses.
Cats
Cats make up roughly 40% of the pet diabetes care market. Rising rates of Type 2 diabetes in felines—driven by obesity, aging, and sedentary lifestyles—have spurred demand for targeted treatments like oral medication and nutritional plans. Enhanced veterinary screening and growing awareness among pet owners are key factors bolstering this segment.
Dogs
Dogs lead the market, comprising nearly 55% of the total share. Most cases of canine diabetes are Type 1, requiring consistent insulin therapy. As pet owners become more proactive, demand for customized diabetic care has risen sharply. Expansion of veterinary services and the availability of dog-specific products are fueling sustained growth.
Horses
Horses represent a niche segment, accounting for about 5% of the pet diabetes care market. Although less prevalent, equine diabetes is gaining visibility due to better diagnostic tools and increased veterinary knowledge. Management strategies focus on dietary control and in some cases, insulin administration. This segment is growing modestly with rising awareness in equine health.
Pet Diabetes Care Market, Segmentation by Device Type
The Pet Diabetes Care Market has been segmented by Device Type into Insulin Delivery Devices, Insulin Delivery Pen, Insulin Syringes, and Glucose Monitoring Devices.
Insulin Delivery Devices
Insulin delivery devices comprise about 38% of the pet diabetes care device market. These tools play a vital role in ensuring accurate insulin administration, which is critical for effective long-term diabetes control in pets. The rising demand for user-friendly and minimally invasive solutions continues to fuel growth in this segment.
Insulin Delivery Pen
Insulin delivery pens hold nearly 22% of the device segment share. Known for their precision dosing and convenient usage, these pens are increasingly preferred by pet owners seeking a stress-free insulin administration method. Their portable and ergonomic design enhances compliance and comfort for both pets and caregivers.
Insulin Syringes
Insulin syringes account for around 25% of the market. Despite being more manual than pens, they remain widely adopted due to their cost-effectiveness and broad availability. These syringes are especially common in emerging markets, where affordability plays a key role.
Glucose Monitoring Devices
Glucose monitoring devices make up close to 15% of the pet diabetes care device market. These systems are crucial for maintaining proper blood sugar control through regular monitoring. Innovations like continuous glucose monitors (CGMs) designed specifically for pets are revolutionizing the way diabetes is managed in veterinary care.
Pet Diabetes Care Market, Segmentation by End User
The Pet Diabetes Care Market has been segmented by End User into Veterinary Clinics, Home Care Settings, Veterinary Hospitals.
Veterinary Clinics
Veterinary clinics lead the pet diabetes care market, capturing nearly 50% of the end-user segment. These clinics provide expert veterinary care, timely diagnosis, and ongoing treatment—making them a top choice for pet owners. A growing number of certified professionals and improved clinic accessibility are fueling this segment’s expansion.
Home Care Settings
Home care settings account for about 30% of the global market. Increasing adoption of pet-friendly insulin delivery tools and glucose monitoring devices enables pet owners to manage diabetes from home. The shift toward convenient, cost-effective, and personalized care is driving notable growth in this space.
Veterinary Hospitals
Veterinary hospitals make up close to 20% of the market share. These institutions are equipped to handle complex or severe diabetic cases that need 24/7 monitoring and advanced care. Rising awareness of chronic pet illnesses and investments in specialized hospital services are supporting steady growth in this segment.
Pet Diabetes Care Market, Segmentation by Geography
In this report, the Pet Diabetes Care Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Pet Diabetes Care Market Share (%), by Geographical Region
North America
North America commands the largest share of the pet diabetes care market at around 40%. Factors such as well-established veterinary infrastructure, high pet ownership, and advanced diagnostic tools contribute to its leadership. Strong presence of key market players and progressive pet healthcare policies further boost growth.
Europe
Europe holds an estimated 25% of the global market. The region is driven by a rise in pet adoption, widespread veterinary coverage, and a growing preference for modern diabetes care solutions. Continuous innovation in insulin delivery systems and diagnostics is advancing the market.
Asia Pacific
Asia Pacific captures nearly 20% of the market, fueled by rising disposable incomes, urban pet ownership, and growing awareness of pet wellness. Countries like China, India, and Japan are emerging as fast-growing markets due to increased spending on pet healthcare infrastructure.
Middle East and Africa
Middle East and Africa account for about 8% of the pet diabetes care market. The region is witnessing steady progress, thanks to the expansion of urban veterinary services, improved pet care culture, and gradual enhancement of healthcare accessibility for companion animals.
Latin America
Latin America contributes close to 7% of the total market share. With Brazil and Mexico leading the charge, the region is experiencing greater investment in veterinary services, improved diagnostics, and education campaigns that promote pet health management.
Pet Diabetes Care Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Pet Diabetes Care Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Increasing Prevalence of Diabetes in Pets
- Growing Pet Ownership and Humanization of Pets
-
Advancements in Veterinary Care and Technology - Rapid advancements in veterinary care and technology are significantly driving the growth of the pet diabetes care market. Innovations in diagnostic tools, glucose monitoring devices, and insulin delivery systems are enabling earlier detection and more effective management of diabetes in companion animals. Modern veterinary clinics now offer comprehensive metabolic screenings, while point-of-care devices allow pet owners to monitor their pets’ glucose levels at home, improving disease control and reducing complications. These advancements are making diabetes care more accessible, precise, and tailored to individual pet needs.
Additionally, the integration of digital health tools and tele-veterinary platforms is enhancing disease tracking and treatment adherence. Pet owners can now receive automated alerts, dosage reminders, and real-time data through connected apps and wearable devices. These technologies foster greater engagement between veterinarians and pet owners, improving compliance with therapeutic protocols. As awareness of pet health continues to rise and pet humanization trends intensify, the adoption of advanced veterinary technologies is expected to further accelerate demand for specialized diabetes care products and services.
Restraints:
- High Cost of Diabetes Care Products and Treatments
- Lack of Awareness in Developing Regions
-
Limited Availability of Veterinary Professionals with Expertise in Diabetes Care - The limited availability of veterinary professionals with expertise in diabetes care is a significant restraint in the pet diabetes care market. While awareness of pet diabetes is growing, many regions lack veterinarians who are adequately trained to diagnose and manage this complex condition. Effective treatment requires not only familiarity with insulin protocols and glucose monitoring but also a deep understanding of nutritional management, behavioral changes, and long-term disease progression. Without specialized guidance, pet owners may struggle to implement consistent care routines, leading to poor outcomes and reduced product utilization.
This shortage is especially pronounced in rural and under-resourced areas, where access to advanced veterinary services is already limited. Even in developed markets, general practitioners may not have the time or training to offer comprehensive diabetes management, resulting in delayed diagnoses or suboptimal treatment plans. The lack of continuing education and certification programs focused specifically on canine and feline diabetes further compounds the issue. Addressing this gap through professional training and awareness initiatives will be essential to improving treatment adoption and expanding the reach of diabetes care solutions for pets.
Opportunities:
- Expansion in Emerging Markets
- Development of Cost-Effective and User-Friendly Solutions
-
Integration of Digital Health Tools and Apps - The growing integration of digital health tools and apps is creating promising opportunities in the pet diabetes care market. As more pet owners seek convenient and proactive ways to manage chronic conditions, mobile applications and connected devices are transforming how diabetes in pets is monitored and treated. These tools allow users to track insulin doses, log blood glucose levels, monitor feeding patterns, and receive personalized reminders—enhancing compliance and overall disease control. The shift toward digital engagement is improving the accuracy of at-home care while reducing the reliance on frequent in-clinic visits.
Advanced mobile platforms also support data sharing between pet owners and veterinary professionals, enabling real-time insights and more informed clinical decisions. Through secure cloud storage and integrated dashboards, veterinarians can assess patterns in glucose levels, treatment responses, and behavioral changes, making it easier to adjust therapeutic plans remotely. This continuous flow of information leads to earlier interventions and fewer complications, ultimately improving the pet’s quality of life and reducing long-term treatment costs.
In addition, the emergence of wearable health devices for pets is fueling demand for smart monitoring solutions. Devices such as glucose sensors and activity trackers now integrate seamlessly with mobile apps, offering a holistic view of the pet’s health and diabetes status. These innovations are particularly beneficial for pets requiring frequent monitoring, providing peace of mind to pet owners and supporting consistent disease management. The ability to visualize trends and receive instant alerts further strengthens user engagement and reinforces the value of digital health technologies in chronic disease care.
As digital adoption accelerates in the veterinary field, companies investing in user-friendly, secure, and interoperable digital solutions are likely to gain a competitive edge. The combination of technology with personalized care represents a powerful shift toward smarter, more efficient pet health management. This integration is expected to drive sustained growth in the pet diabetes care market by meeting the evolving expectations of tech-savvy pet owners and forward-thinking veterinary providers alike.
Pet Diabetes Care Market Competitive Landscape Analysis
Key players in Pet Diabetes Care Market include,
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Market Share Analysis
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Animal Type
- Market Snapshot, By Device Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Pet Diabetes Care Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Prevalence of Diabetes in Pets
- Growing Pet Ownership and Humanization of Pets
- Advancements in Veterinary Care and Technology
- Restraints
- High Cost of Diabetes Care Products and Treatments
- Lack of Awareness in Developing Regions
- Limited Availability of Veterinary Professionals with Expertise in Diabetes Care
- Opportunities
- Expansion in Emerging Markets
- Development of Cost-Effective and User-Friendly Solutions
- Integration of Digital Health Tools and Apps
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Pet Diabetes Care Market, By Drug Type, 2021 - 2031 (USD Million)
- Insulin Therapy
- Oral Medication
- Pet Diabetes Care Market, By Animal Type, 2021 - 2031 (USD Million)
- Cats
- Dogs
- Horses
- Pet Diabetes Care Market, By Device Type, 2021 - 2031 (USD Million)
- Insulin Delivery Devices
- Insulin Delivery Pen
- Insulin Syringes
- Glucose Monitoring Devices
- Pet Diabetes Care Market, By End User, 2021 - 2031 (USD Million)
- Veterinary Clinics
- Home Care Settings
- Veterinary Hospitals
- Pet Diabetes Care Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Pet Diabetes Care Market, By Drug Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Abbot Laboratories, Inc
- Virbac
- Medtronic plc
- Johnson & Johnson Services, Inc
- Roche Diagnostics
- Bio-Rad Laboratories, Inc
- Novo Nordisk A/S
- Zoetis Inc
- Terumo Corporation
- Boehringer Ingelheim International GmbH
- IDEXX Laboratories
- Johnson & Johnson Services, Inc
- Terumo Corporation
- Eli Lilly and Company
- Vetoquinol S.A
- Company Profiles
- Analyst Views
- Future Outlook of the Market